4th Apr 2013 17:10
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 28 March 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.25 per Ordinary Share, and notional ADSs at a price of $46.43 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2013 to 31 March 2013:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,786.885 | |
Professor Sir Roy Anderson | 594.262 | |
Dr Stephanie Burns |
| 497.227 |
Stacey Cartwright | 471.311 | |
Sir Crispin Davis | 1,885.246 | |
Lynn Elsenhans | 1,128.489 | |
Judy Lewent | 486.418 | |
Sir Deryck Maughan | 994.454 | |
Dr Daniel Podolsky | 1,134.975 | |
Tom de Swaan | 553.279 | |
Jing Ulrich | 313.469 | |
Sir Robert Wilson | 594.262 | |
The Company and the Non-Executive Directors were informed of these allocations on 3 April 2013.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
4 April 2013
Related Shares:
Glaxosmithkline